Our editor Laura Hughes highlights her five must-read articles for this week.
1. FDA says coronavirus not hindering efforts to monitor products from China
The Food and Drug Administration (FDA) has said its efforts to monitor medical products from China are not being hindered despite its inability to conduct inspections in the country due to the coronavirus.
2. Bringing 3D printed medical models to life
Scott Drikakis, healthcare segment leader - Americas, Stratasys, explores how 3D printing could enable medical device manufacturers to overcome current limitations, improve clinical validation, and change the game of medical device testing.
3. Radiation-free solution announced for 3D printing before surgery
A European partnership has received funds to develop an end-to-end radiation-free solution for 3D printed orthopaedic models for pre-operative planning.
4. How to optimise your extrusion process
Glen Guillemette, president of Guill Tool & Engineering, explains how manufacturers can optimise the extrusion process.
5. How the biosimilar market is impacting drug delivery design
Head of content, Lu Rahman, speaks to medical device manufacturer, Owen Mumford, about the findings of its recent report scoping the near-term competitive biosimilars market in the USA and Europe, and its impact on drug delivery device design.